Ghrelin: Difference between revisions
imported>Gareth Leng |
imported>Gareth Leng No edit summary |
||
| Line 3: | Line 3: | ||
'''Ghrelin''' is a [[hormone]] produced by [[P/D1 cell]]s lining the fundus of the human [[stomach]] that stimulate [[appetite]] <ref>[http://www.fasebj.org/cgi/content/full/18/3/439 Bowers C ''et al.'']</ref>. In rodents, X/A-like cells produce ghrelin. The discovery of ghrelin was reported by Kojima ''et al.'' in 1999. <ref>Kojima M ''et al.'' (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. ''[[Nature (journal)|Nature]]'' 402:656-60. PMID 10604470.</ref> The name is based on its role as a ''growth hormone-releasing peptide'', with reference to the [[Proto-Indo-European language|Proto-Indo-European]] root ''ghre'', meaning ''to grow''. Originally identified as the endogenous ligand for the 'growth hormone secretaguge (GHS) receptor, it was first thought to be mainly involved in the regulation of [[growth hormone]] secretion from the [[anterior pituitary gland]].; however it was soon found to be a potent orexigen. Plasma concentrations of ghrelin increase progressively before meals and decrease after meals. In some respects it can be considered as a counterpart of the hormone [[leptin]], produced by [[adipose tissue]], which suppresses appetite. | '''Ghrelin''' is a [[hormone]] produced by [[P/D1 cell]]s lining the fundus of the human [[stomach]] that stimulate [[appetite]] <ref>[http://www.fasebj.org/cgi/content/full/18/3/439 Bowers C ''et al.'']</ref>. In rodents, X/A-like cells produce ghrelin. The discovery of ghrelin was reported by Kojima ''et al.'' in 1999. <ref>Kojima M ''et al.'' (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. ''[[Nature (journal)|Nature]]'' 402:656-60. PMID 10604470.</ref> The name is based on its role as a ''growth hormone-releasing peptide'', with reference to the [[Proto-Indo-European language|Proto-Indo-European]] root ''ghre'', meaning ''to grow''. Originally identified as the endogenous ligand for the 'growth hormone secretaguge (GHS) receptor, it was first thought to be mainly involved in the regulation of [[growth hormone]] secretion from the [[anterior pituitary gland]].; however it was soon found to be a potent orexigen. Plasma concentrations of ghrelin increase progressively before meals and decrease after meals. In some respects it can be considered as a counterpart of the hormone [[leptin]], produced by [[adipose tissue]], which suppresses appetite. | ||
Receptors for ghrelin are expressed in the anterior pituitary and in several areas of the central nervous system, but at particularly high densities by neurons in the [[arcuate nucleus]] and the [[ventromedial hypothalamus]]. The ghrelin receptor is a G-protein coupled membrane receptor, formerly known as the GHS receptor (growth hormone secretagogue receptor). There is also evidence that ghrelin may also be made by a small population of neurons in the arcuate nucleus. | Receptors for ghrelin are expressed in the anterior pituitary and in several areas of the central nervous system, but at particularly high densities by neurons in the [[arcuate nucleus]] and the [[ventromedial hypothalamus]]. The ghrelin receptor is a G-protein coupled membrane receptor, formerly known as the GHS receptor (growth hormone secretagogue receptor). There is also evidence that ghrelin may also be made by a small population of neurons in the arcuate nucleus. | ||
increase food intake and increase fat mass<ref>{{cite journal |author=Lall S ''et al.'' |title=Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues |journal=Biochem Biophys Res Commun |volume=280 |pages=132–138 |year=2001 |pmid=11162489 |doi=10.1006/bbrc.2000.4065}}</ref><ref>{{cite journal |author=Tschöp M ''et al.'' |title=Ghrelin induces adiposity in rodents |journal=Nature |volume=407 |pages=908–13 |year=2000 |doi=10.1038/35038090}}</ref> by an action exerted at the level of the hypothalamus. They activate cells in the [[arcuate nucleus]]<ref>{{cite journal |author=Hewson AK, Dickson SL|title=Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats |journal=J Neuroendocrinol |volume=12 |pages=1047–9 |year=2000 |pmid=11069119 |doi=10.1046/j.1365-2826.2000.00584.x}}</ref><ref>{{cite journal |author=Dickson SL ''et al.''|title=Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons |journal=Neuroscience|volume=54 |pages=303–6 |year=1993 |pmid=8492908 |doi=10.1016/0306-4522(93)90197-N}}</ref> that include the orexigenic neuropeptide Y (NPY) neurons.<ref>{{cite journal |author=Dickson SL, Luckman SM. |title=Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6 |journal=Endocrinology |volume=138 |pages=771–7 |year=1997 |pmid=9003014 |doi=10.1210/en.138.2.771}}</ref> Ghrelin-responsiveness of these neurones is both leptin- and insulin-sensitive.<ref>{{cite journal |author=Hewson AK ''et al.''|title=The rat arcuate nucleus integrates peripheral signals provided by leptin, insulin, and a ghrelin mimetic |journal=Diabetes. |volume=51 |pages=3412–9. pmid=12453894 |doi=10.2337/diabetes.51.12.3412|year=2002}}</ref> Ghrelin also activates the mesolimbic cholinergic-dopaminergic reward link, a circuit that communicates the hedonic and reinforcing aspects of natural rewards, such as food, as well as of addictive drugs, such as ethanol.<ref>{{cite journal |author=Jerlhag E ''et al.''|title=Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: Implications for its involvement in brain reward |journal=Addiction Biol |volume=11 |pages=45–54 |year=2004 |pmid=16759336 |doi=10.1111/j.1369-1600.2006.00002.x}}</ref><ref>{{cite journal |author= Jerlhag E ''et al.'' |title= Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens |journal= Addiction Biol |volume=12 |pages=6–16 |year=2007| pmid=17407492 |doi=10.1111/j.1369-1600.2006.00041.x}}</ref> | |||
<ref>{{cite journal |author= Hewson AK ''et al.''|title=The rat arcuate nucleus integrates peripheral signals provided by leptin, insulin, and a ghrelin mimetic |journal= Diabetes |volume=51 |pages=3412–9. | |||
|year=2002 |pmid=12453894 |doi=10.2337/diabetes.51.12.3412 }}</ref> | |||
Ghrelin exists in an inactive (pure peptide) and an active (octanoylated) form (see [[Hexatropin]]). Other side chains than octanoyl were also observed. | Ghrelin exists in an inactive (pure peptide) and an active (octanoylated) form (see [[Hexatropin]]). Other side chains than octanoyl were also observed. | ||
Revision as of 09:45, 13 March 2009
Ghrelin is a hormone produced by P/D1 cells lining the fundus of the human stomach that stimulate appetite [1]. In rodents, X/A-like cells produce ghrelin. The discovery of ghrelin was reported by Kojima et al. in 1999. [2] The name is based on its role as a growth hormone-releasing peptide, with reference to the Proto-Indo-European root ghre, meaning to grow. Originally identified as the endogenous ligand for the 'growth hormone secretaguge (GHS) receptor, it was first thought to be mainly involved in the regulation of growth hormone secretion from the anterior pituitary gland.; however it was soon found to be a potent orexigen. Plasma concentrations of ghrelin increase progressively before meals and decrease after meals. In some respects it can be considered as a counterpart of the hormone leptin, produced by adipose tissue, which suppresses appetite. Receptors for ghrelin are expressed in the anterior pituitary and in several areas of the central nervous system, but at particularly high densities by neurons in the arcuate nucleus and the ventromedial hypothalamus. The ghrelin receptor is a G-protein coupled membrane receptor, formerly known as the GHS receptor (growth hormone secretagogue receptor). There is also evidence that ghrelin may also be made by a small population of neurons in the arcuate nucleus.
increase food intake and increase fat mass[3][4] by an action exerted at the level of the hypothalamus. They activate cells in the arcuate nucleus[5][6] that include the orexigenic neuropeptide Y (NPY) neurons.[7] Ghrelin-responsiveness of these neurones is both leptin- and insulin-sensitive.[8] Ghrelin also activates the mesolimbic cholinergic-dopaminergic reward link, a circuit that communicates the hedonic and reinforcing aspects of natural rewards, such as food, as well as of addictive drugs, such as ethanol.[9][10] [11]
Ghrelin exists in an inactive (pure peptide) and an active (octanoylated) form (see Hexatropin). Other side chains than octanoyl were also observed.
Role in disease
Ghrelin levels in the plasma of obese individuals are lower than those in leaner individuals. Yildiz et al (2004) found that the level of ghrelin increases during the time of day from midnight to dawn in thinner people, suggesting a flaw in the circadian system of obese individuals. Professor Cappuccio of the University of Warwick has recently discovered that short sleep duration may also lead to obesity, through an increase of appetite via hormonal changes. Lack of sleep produces Ghrelin, which stimulates appetite and creates less leptin which, amongst its many other effects, suppresses appetite.
Those suffering from the eating disorder anorexia nervosa appear to have high plasma levels of ghrelin. Ghrelin levels are also high in patients who have cancer-induced cachexia (Garcia et al, 2005).
Prader Willi Syndrome is another example of high levels of ghrelin, but here the ghrelin level are associated with high food intake.
At least one study found that gastric bypass surgery not only reduces the gut's capacity for food, but also dramatically lowers ghrelin levels (Cummings et al, 2002).
Relation to obestatin
Obestatin is a hormone that was found, in late 2005, to decrease appetite. Both obestatin and ghrelin are encoded by the same gene; the gene's product breaks apart to yield the two peptide hormones [12]. The purpose of this mechanism is unknown.
Anti-Obesity Vaccine
Recently Scripps research scientists have developed an anti-obesity vaccine, which is directed against the hormone ghrelin. The vaccine uses the immune system, specifically antibodies, to bind to selected targets, directing the body's own immune response against them. This prevents ghrelin from reaching the central nervous system, thus producing a desired reduction in weight gain.
References
- ↑ Bowers C et al.
- ↑ Kojima M et al. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-60. PMID 10604470.
- ↑ Lall S et al. (2001). "Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues". Biochem Biophys Res Commun 280: 132–138. DOI:10.1006/bbrc.2000.4065. PMID 11162489. Research Blogging.
- ↑ Tschöp M et al. (2000). "Ghrelin induces adiposity in rodents". Nature 407: 908–13. DOI:10.1038/35038090. Research Blogging.
- ↑ Hewson AK, Dickson SL (2000). "Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats". J Neuroendocrinol 12: 1047–9. DOI:10.1046/j.1365-2826.2000.00584.x. PMID 11069119. Research Blogging.
- ↑ Dickson SL et al. (1993). "Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons". Neuroscience 54: 303–6. DOI:10.1016/0306-4522(93)90197-N. PMID 8492908. Research Blogging.
- ↑ Dickson SL, Luckman SM. (1997). "Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6". Endocrinology 138: 771–7. DOI:10.1210/en.138.2.771. PMID 9003014. Research Blogging.
- ↑ Hewson AK et al. (2002). "The rat arcuate nucleus integrates peripheral signals provided by leptin, insulin, and a ghrelin mimetic". Diabetes. 51: 3412–9. pmid=12453894. DOI:10.2337/diabetes.51.12.3412. Research Blogging.
- ↑ Jerlhag E et al. (2004). "Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: Implications for its involvement in brain reward". Addiction Biol 11: 45–54. DOI:10.1111/j.1369-1600.2006.00002.x. PMID 16759336. Research Blogging.
- ↑ Jerlhag E et al. (2007). "Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens". Addiction Biol 12: 6–16. DOI:10.1111/j.1369-1600.2006.00041.x. PMID 17407492. Research Blogging.
- ↑ Hewson AK et al. (2002). "The rat arcuate nucleus integrates peripheral signals provided by leptin, insulin, and a ghrelin mimetic". Diabetes 51: 3412–9.. DOI:10.2337/diabetes.51.12.3412. PMID 12453894. Research Blogging.
- ↑ Zhang et al. (2005)
- Garcia JM et al' (2005) Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia." J Clin Endocrinol Metab 90:2920-6. PMID 15713718.
- Yildiz BO et al. (2004) "Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity." Proc Natl Acad Sci U S A 101:10434-9. PMID 15231997.
- Cummings DE, et al. (2002) Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery. New England Journal of Medicine 346:1623-1630.
- Zhang JV et al. (2005) Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310:996-999. PMID 16284174.